Summary EL4 tumour cells maintained in culture were separated by FACS analysis to Ly-6.2 negative and Ly-6.2 positive subsets. The Ly-6.2 negative subset gained expression of this determinant on repeated in vivo passage in C57BL/6 mice. Both subsets injected intraperitoneally or intramuscularly in syngeneic mice induced identical changes in lymphocyte profiles. There was generalised lymphocytolysis in both T-and B-cell compartments. The Lyt-l +, 2-T-lymphocytes were more susceptible to cytolysis causing an alteration of the proportional representation of the Lyt-2+ subset from 30% of splenic T-cells Tumour cell populations are heterogeneous with respect to a variety of properties that influence their growth and survival in the host (Poste & Fidler, 1980; Nicholson, 1984) . Development of heterogeneity is thought to be part of the tumorigenic process causing the progression of primary tumours from the benign to the malignant state (Harris et al., 1982; Fidler & Hart, 1982) . This may involve the selection of stable subpopulations of cells in the original tumour which possess intrinsic properties that promote dissemination; it may also reflect the acquisition of such properties due to genetic alterations that may arise under the influence of selective pressures of the host response (Layton & Franks, 1984; Bernstein & Weinberg, 1985) .
Tumour cell populations are heterogeneous with respect to a variety of properties that influence their growth and survival in the host (Poste & Fidler, 1980; Nicholson, 1984) . Development of heterogeneity is thought to be part of the tumorigenic process causing the progression of primary tumours from the benign to the malignant state (Harris et al., 1982; Fidler & Hart, 1982) . This may involve the selection of stable subpopulations of cells in the original tumour which possess intrinsic properties that promote dissemination; it may also reflect the acquisition of such properties due to genetic alterations that may arise under the influence of selective pressures of the host response (Layton & Franks, 1984; Bernstein & Weinberg, 1985) .
Comparative examinations of metastatic variants and parental tumour lines have centred on the study of cell surface compositions of neoplastic cell lines. Quantitative differences in terminal cell surface carbohydrates (Fogl et al., 1983) , altered cell surface protein composition after enzyme treatment (Sargent et al., 1983) and differences in glycoprotein expression (Altevogt et al., 1982) have all been shown to contribute to the metastatic capacity of different tumour cell lines. The most notable finding to date is an inverse correlation between metastatic potential and the expression of major histocompatibility complex (MHC) molecules (Wallich et al., 1985; Hui et al., 1984; Albino et al., 1981; Natali et al., 1983) .
In this study we demonstrate that in the EL4 murine Tcell leukaemia model there is a direct relationship between expression of the lymphocyte differentiation antigen Ly-6.2 and dissemination of the tumour cells to the spleen and lymph nodes from an intramuscular site. EL4 tumour cells maintained in culture are heterogeneous with respect to Ly-6.2 expression. Tumour cells selected by fluorescence activated cell sorter (FACS) analysis on the basis of lack of expression of Ly-6.2, gained this determinant on in vivo passage while parallel in vitro cultures remained negative. To determine the biological effects of Ly-6.2 expression on EL4 tumour cells, Ly-6.2-and Ly-6.2+ tumour cells were injected into syngeneic C57BL/6 mice and their effects on lymphocyte profiles and capacity to metastasize into the lymphoid organs examined. (Oi & Herzenberg, 1979) as a second step reagent. Monoclonal antibodies against Thy-I and Lyt-2 were derived from hybridoma clones 53-2.1 and 53-6.7 respectively (Ledbetter & Herzenberg, 1979) . They were used as direct fluorescein conjugates.
Fluorescence staining of cell suspensions This was carried out as previously described (MattosianRogers et al., 1982) . Briefly cells were suspended in RPMI containing 1% foetal calf serum and 0.1% NaN3 and incubated for 30min on ice with saturating levels of the monoclonal reagents. Cell suspensions reacting with anti-Ly-6.2 were washed and incubated for a further 30min with fluorescein-conjugated anti-allotype monoclonal reagent antiIgh-la , the second step reagent. Fluorescence profiles were obtained using a modified FACS II (BectonDickinson FACS Systems, Mountain View, California).
Separation of EL4 tumour cells to Ly-6.2-and Ly-6.2+ subpopulations Tumour cells were stained with anti-Ly-6.2 under sterile conditions as described above. The staining profile was examined by fluoroscence activated cell sorter (FACS) analysis and the criteria for sorting the dullest and the brightest cells were established. The sorted populations were washed and incubated in culture medium at 1 x 10 mlP1. They were counted at 3 day intervals and reseeded at 1 x IO1 ml-1 in fresh culture medium.
Experimental design Groups of age matched female C57BL/6 mice were injected with 5 x 105 Ly-6.2-or Ly-6.2+ EL4 tumour cells either intraperitoneally (i.p.) or intramuscularly (i.m.) in one hind leg. Some groups were observed for duration of survival while others were examined for tumour metastasis and alterations in lymphocyte profiles. At weekly intervals the thymus, lymph nodes and spleen were removed and cell suspensions from these organs were stained with monoclonal reagents and analysed by fluorimetry. Tumour cells were also removed from the peritoneal cavity or the solid intramuscular growth and the staining characteristics examined.
Results
Gain of Ly-6.2 expression of EL4 tumour cells passaged in ascites EL4 tumour cells maintained by serial passage in culture medium were heterogeneous with respect to Ly-6.2 expression. FACS analysis of the Ly-6.2 staining profile of such tumour cells is shown in Figure 1 . When the cultured tumour cells were injected into C57BL/6 mice either i.p. or i.m. there was an increase in expression of Ly-6.2 so that tumour cells obtained from the second passage were over 90% Ly-6.2 positive. Ly-6.2 staining profiles of first and second passage tumour cells are shown in Figure la Fluorescence-activated cell sorting of EL4 cells to Ly-6.2-and Ly-6.2+ subpopulations In vitro maintained EL4 tumour cells were stained with antiLy-6.2 under sterile conditions and sorted to Ly-6.2-and Ly-6.2 + subpopulations. The fluorescence intensity of the unsorted population on the arbitrary log10 scale of 0-4 ranged from 0.8 to 3.5. The fluorescence intensity of the Ly-6.2-population ranged from 0.8 to 1.8 and the Ly-6.2+ population from 1.8 to 3.5. To eliminate the possibility of contamination sorting criteria were set to select cells with a fluorescence intensity of 0.8 to 1.2 and 2.0 to 3.5 for the Ly-6.2-and Ly-6.2 + populations respectively. Ly-6.2-cells above 1.2 log units and Ly-6.2+ cells of intermediate brightness which fell in the intervening 0.8 log1o units were
The fluorescence patterns of the sorted populations revealed absolute purity of separation ( Figure  2 ). The two populations were maintained as separate lines in culture and their rate of growth and staining characteristics examined for a number of passages. The Ly-6.2 negative line maintained this phenotype for at least 18 passages during a period of 9 weeks. During this time the Ly-6.2 positive line showed a gradual loss of Ly-6.2 expression. The rate of growth of the two sublines was identical during the 9 week observation period.
Effects of Ly-6.2-and Ly-6.2+ EL4 tumour cells injected intraperitoneally into syngeneic mice The separated Ly-6.2 negative and Ly-6.2 positive EL4 tumour cells were injected i.p. into groups of five C57BL/6 female mice. At weekly intervals the staining patterns of the tumour cells recovered from the mice and the lymphocytes obtained from the thymus spleen and lymph nodes were examined.
At the end of the first week there were no noticeable changes in the sizes of the lymphoid organs; lymphocyte profiles were also unchanged compared to normal mice. At the end of the second week the spleens of the mice that had received the Ly-6.2+ tumour cells were enlarged while the spleens of mice injected with Ly-6.2-tumour cells appeared normal (Table I) . Flow-cytometric analysis revealed similar deviations from normal lymphocyte profiles for both groups of mice. There was a reduction in number of splenic Thy-I + cells from 30-35% in normal mice to 10-15% in the tumour bearing mice. Over 90% of these Thy-i + cells were Lyt-2+ whereas in the normal mouse Lyt-2+ cells comprise 30% of splenic T-cells ( Figure 3 ). Similar changes in lymphocyte profile were noted in the lymph nodes of both groups of mice.
The thymuses of all mice from both groups showed marked regression. The thymocytes that were recovered were phenotypically identical to mature medullary thymocytes. Lyt-2 staining cells were reduced from 70-80% in the normal thymus to 28-30% in both groups of mice. There was a marked decrease in brightness of Thy-I ' cells and an enrichment of Ly-6.2+ thymocytes from undectable levels in normal C57BL/6 mice to 50-60% in the tumour bearing mice (Figure 4 ). Tumour cells recovered from the peritoneal cavity of mice from the two groups did not show identical staining profiles. Mice that were injected with the Ly-6.2-subline yielded a tumour cell population that was 50-60% Ly-6.2+ while tumour cells recovered from the mice that received the Ly-6.2+ EL4 cells were almost totally Ly-6.2 positive ( Figure 5 ).
Metastatic potential of Ly-6.2-and Ly-6.2+ tumour cells injected intramuscularly into syngeneic hosts When Ly-6.2-and Ly-6.2+ tumour cells were injected i.m. similar changes to those described above occurred in the lymphocyte and thymocyte populations during the second Fluorescence intensity (log,6) week of tumour growth except in 2 out of 5 mice that were injected with Ly-6.2-cells. In the thymuses of these mice there were small reductions in the Thy-l bright and Lyt-2+ populations and a small increase in the Ly-6.2+ cells suggesting an intermediate stage in the progression towards the medullary thymocyte profile (Figure 4) . By this route of tumour injection, however, the spleens from both groups of mice injected with Ly-6.2+ and Ly-6.2-tumour cells were greatly enlarged (see Table I ). (Figure 6c ). This population thus represented invading tumour cells. Cells in population (C) were only marginally brighter than the background and were also Thy-1 -, Lyt-l -and Lyt-2 -; they were probably of the monocyte-macrophage series. Even though the spleens of mice injected with Ly-62-EL4 tumour cells were enlarged during the-second and third weeks of tumour growth, FACS analysis revealed only one population of large cells corresponding to population (C) which were not Ly-6.2+ and not tumour cells by size or staining criteria (Figure 6d ) even though by the third week at least 50% of tumour cells recovered from the solid intramuscular mass were Ly-6.2+ ( Figure 5) .
In all mice injected with the Ly-6.2 positive subline of EL4 the tumour cells also metastasised to the mesenteric lymph nodes. All the cells in the size range of tumour cells were Ly-6.2+ as were the tumour cells from the intramuscular mass ( Figure 7 ). Only in 2 mice out of 6 injected with the Ly-6.2-subline were the mesenteric lymph nodes invaded. The cells in the size range of tumour cells in these lymph nodes were both Ly-6.2-and Ly-6.2+ as were the tumour cells from the intramuscular mass (Figure 8 ).
Discussion
In this study we have demonstrated that Ly-6.2 antigen expression on EL4 tumour cells gradually declines in culture but the antigen is re-expressed by in vivo passage in syngeneic hosts (Figure 1 ). An Ly-6.2-subline separated by FACS analysis maintained this phenotype over a long period of in vitro passages while an Ly-6.2 + subline gradually became heterogeneous in expression of this determinant with a proportion of cells becoming Ly-6.2-. The Ly-6.2-and Ly6.2+ tumour sublines had identical growth patterns in vitro, produced similar sized growths when injected subcutaneously or i.m. but mice injected with Ly-6.2-tumour cells survived a week longer than those injected with the same number of Ly-6.2 + cells. The latter died in three weeks.
There were no changes in lymphocyte profiles after one week of tumour growth in either the Ly-6.2-or the Ly-6.2+ tumour bearing groups of mice. A positive immune response to EL4 by C57BL/6 mice one week after tumour challenge has been reported (Apffel et al., 1966; Kemp et al., 1973) which is consistent with an uncompromised lymphoid a- system. After the second week of tumour growth, when the immune response is known to be impaired, there were marked alterations in lymphocyte profiles. These were identical for both Ly-6.2+ and Ly-6.2-tumour bearing mice and involved regression of the thymus with the residual cells expressing the phenotypes of mature medullary cells ( Figure  4 ) as described for C57BL/6 mice after a single i.p. injection of 125mgkg-t hydrocortisone acetate (Micklem et We have shown that Lyt-2+ cells are selectively resistant to corticosteroid treatment, both in peripheral lymphoid organs and also within the putative mature thymocyte population (Rogers & Matossian-Rogers, 1981) . Thus selective lymphocytolysis with a resultant predominance of the Lyt-2+ subset is a characteristic of both tumour bearing and corticosteroid treated mice and suggests a common mechanism for the immunnsunnressed state in these two conditions. Several bulk of cells causing spleen enlargement in both groups of leens of these mice were of a size intermediate between lymphocytes and tumour cells and were negative for both T-and B-cell markers. Similar cells, probably belonging to the monocytemacrophage series were noted in C3H mice carrying the syngeneic Gardner tumour. These cells were strongly cytostatic against the Gardner tumour in in vitro assays when suppressor T-cells were removed from the cell population (Matossian-Rogers & Taidi, 1983 (1982) which demonstrates a number of differences in cell surface glycoproteins between a murine T-lymphoma line Eb and its metastatic variant ESb. These differences include loss of Thy-1, Lyt-2,3 as well as Ly-6 by the metastatic variant. Such widespread differences in cell phenotype suggest the unrelatedness of the parental and the metastatic variant cell lines. The occasional development of ESb variants from cloned Eb tumour cell populations was noted by these workers in tumours passaged in ascites and taken as evidence for the original identity of the two cell lines.
Metastatic variants derived in vivo may be due to fusion with normal host cells (De Baetselier et al., 1984) introducing surface determinants of different cell lineages to the tumour variant and consequently different organ colonising potential. The in vivo increase of Ly-6.2 in our experiments directly correlates with metastatic potential and both characteristics are lost by in vitro culture of the tumour cell population. Other surface determinants such as Thy-l and T30 were not altered by in vivo or in vitro culture.
The mechanism for gain or loss of Ly-6.2 is not known at present but cannot be explained by random phenotypic drift which occurs during the proliferation of single cell clones (Poste et al., 1981 (Poste et al., , 1982 . In the present experiments the stringent criteria for separation of Ly-6.2-and Ly-6.2+ cells resulted in pure subpopulations, the former of which retained its phenotypic characteristics in vitro and the latter in vivo. It is well known that polyclonal but uniform populations of tumour cells are more phenotypically stable and less susceptible to diversification than populations derived from single cell clones (Miner et al., 1982) . The increased expression of Ly-6.2 is thus a specific event during the metastatic cascade and is applicable to the tumour population as a whole. The mechanism for this increase may be enhancement or induction of mRNA analogous to the proposed mechanism for interferon induced modulation of major histocompatibility complex (MHC) gene products (Rosa et al., 1985) or other mechanisms leading to activation or expression of genes such as hypomethylation of DNA (Frost et al., 1984) . Gradual hypomethylation due to local in vivo environmental conditions may result in the expression of genes which are involved in tumour progression and increased metastatic aggressiveness. The rate of conversion of Ly-6.2-tumour cells to the Ly-6.2+ phenotype suggests that the mechanisms in operation must be under the influence of inductive rather than selective processes. Thus certain host or tumour induced signals or host-tumour cell interactions initiate the gene activation or amplification mechanisms or the transcriptional and translational controls that may be involved in the process of antigen expression.
It is now generally accepted that metastatic capacity of tumour cells correlates with phenotypic variation (Albino et al., 1981; Natali et al., 1983; Stackpole, 1983) rather than ultrastructural differences between metastatic and nonmetastatic variants (Franks & Layton, 1984) . Experimental induction of MHC molecules in some tumour cell lines lacking in these determinants has demonstrated the involvement of immune phenomena in modulating metastatic spread (Hui et al., 1984; Wallich et al., 1985) . Other cell surface molecular differences between metastatic and nonmetastatic tumour variants are thought to affect cell-cell and cell-tissue interactions influencing adhesiveness and organ colonising properties of tumour cells (Reiber & Reiber, 1981; Sargent et al., 1983) . Non-specific defence mechanisms have also been shown to control tumour cell dissemination (Barlozzari et al., 1985) .
In view of the multiplicity of mechanisms operating in the inhibition of metastatic spread of tumours a number of model systems must be examined to understand the phenomenon of metastasis more fully. In the model system presented in this report the cell surface modifications affecting metastasis occur naturally in-vivo and dissemination is spontaneous from a primary site. This is clinically more relevant than models of metastasis where the tumour cells are introduced directly into the blood stream by i.v. inoculation (Sinha & Goldenberg, 1974; Tarin & Price, 1979; Reiber & Reiber, 1981) since organ colonisation by this method does not necessarily indicate the potential for spontaneous dissemination from a locally growing tumour (Stackpole, 1981) . Further study of this model may shed light upon the normal physiological role of Ly-6.2 on lymphoid cells and the intrinsic capacity of tumour cells to initiate their metastatic spread.
